Tetanus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Tetanus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Report Format: PDF+Excel | Report ID: SR112024A8949
Buy Now

 Market Overview:

The 7 major tetanus markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.46% during 2024-2034.

Report Attribute
Key Statistics
Base Year 
2023
Forecast Years  2024-2034
Historical Years 
2018-2023
Market Size in 2023
US$ 1.1 Billion
Market Forecast in 2034
US$ 1.6 Billion
Market Growth Rate 2024-2034
3.46%


The tetanus market has been comprehensively analyzed in IMARC's new report titled "Tetanus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Tetanus, also known as lockjaw, refers to a serious bacterial infection caused by the bacterium Clostridium tetani. The bacteria can enter the body through a wound or a cut, and they release a potent toxin that affects the muscles and nerves. The muscles most commonly afflicted are those in the jaw, which can cause difficulty opening the mouth and swallowing. However, the infection can spread to various other parts of the body, causing muscle stiffness and spasms throughout. Some individuals suffering from the disease may also experience a fever, often accompanied by sweating. The diagnosis of tetanus typically relies on a combination of the patient's clinical symptoms, medical history, and laboratory tests. If there is an open wound, a sample might be taken to culture it and identify the presence of bacteria. The healthcare provider may also perform a complete blood count to evaluate any signs of infection or abnormalities in the blood cells. In some cases, electromyography may be further conducted to determine the electrical activity in muscles. This test can help to confirm the presence of muscle spasms and identify the characteristic pattern associated with the condition.

Tetanus Market

The increasing cases of deep puncture wounds, burns, crush injuries, etc., which provide a suitable breeding ground for the bacteria to multiply, are primarily driving the tetanus market. In addition to this, the rising prevalence of inadequate immunization against the illness that enhances the risk of contracting the infection is also creating a positive outlook for the market. Moreover, the widespread adoption of intravenous antibiotics, such as penicillin, metronidazole, doxycycline, etc., to kill bacteria and prevent the release of hazardous chemicals in patients is further bolstering the market growth. Apart from this, the emerging popularity of neuromuscular blockers, since they work by blocking the transmission of nerve impulses at the myoneural junction to alleviate the severe muscle spasms and rigidity associated with the condition, is acting as another significant growth-inducing factor. Additionally, the inflating demand for tetanus immune globulin (TIG) therapy to neutralize the bacterial toxin and prevent its harmful effects by providing immediate passive immunity against the pathogen is expected to drive the tetanus market during the forecast period.

IMARC Group's new report provides an exhaustive analysis of the tetanus market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for tetanus and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the tetanus market in any manner.

Time Period of the Study

  • Base Year: 2023
  • Historical Period: 2018-2023
  • Market Forecast: 2024-2034


Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the tetanus market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the tetanus market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current tetanus marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance
     
Drugs Company Name
Adacel (DTaP vaccine) Sanofi
Boostrix (DTaP vaccine adult) GlaxoSmithKline
Daptacel (DTaP vaccine paediatric Tripacel) Sanofi
Kinrix (DTaP-poliovirus vaccine paediatric) GlaxoSmithKline
Tenivac (Tetanus and Diphtheria Toxoids Adsorbed) Sanofi


*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

  • How has the tetanus market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
  • What was the country-wise size of the tetanus market across the seven major markets in 2023 and what will it look like in 2034?
  • What is the growth rate of the tetanus market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?
     

Epidemiology Insights

  • What is the number of prevalent cases (​2018-2034​) of tetanus across the seven major markets?
  • What is the number of prevalent cases (​2018-2034​) of tetanus by age across the seven major markets?
  • What is the number of prevalent cases (​2018-2034​) of tetanus by gender across the seven major markets?
  • How many patients are diagnosed (​2018-2034​) with tetanus across the seven major markets?
  • What is the size of the tetanus patient pool (2018-2023) across the seven major markets?
  • What would be the forecasted patient pool (2024-2034) across the seven major markets?
  • What are the key factors driving the epidemiological trend of tetanus?
  • What will be the growth rate of patients across the seven major markets?
     

Tetanus: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for tetanus drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the tetanus market?
  • What are the key regulatory events related to the tetanus market?
  • What is the structure of clinical trial landscape by status related to the tetanus market?
  • What is the structure of clinical trial landscape by phase related to the tetanus market?
  • What is the structure of clinical trial landscape by route of administration related to the tetanus market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Tetanus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More